Next 10 |
home / stock / orth:cc / orth:cc news
Toronto, Ontario--(Newsfile Corp. - Le 7 septembre/September 2022) - Ortho Regenerative Technologies Inc. (ORTH) has announced a name and symbol change to ChitogenX Inc. (CHGX) Shares will begin trading under the new name and symbol and with a new CUSIP number on September 12, 2022. Di...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX Canada NewsWire New Name to better represent Company's proprietary technology platform expanded applications beyond orthopedics MONTREAL , Sept. 7, 2022 /CNW Telbec/ ...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL Canada NewsWire First patient surgery completed; additional surgeries already scheduled 8 clinical centres now fully initi...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS Canada NewsWire MONTREAL , July 22, 2022 /CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) (" Ortho " o...
ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FIRST QUARTER 2023 RESULTS Canada NewsWire Patients recruitment initiated for U.S. Phase I/II rotator cuff tear repair clinical trial in June 2023 Philippe Deschamps appointed as new CEO Signing of M...
ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL Canada NewsWire Contracting procedures completed for 6 of the 10 clinical trial sites 5 sites fully activated, with ongoing patien...
ORTHO REGENERATIVE TECHNOLOGIES RECEIVES $500,000 AXELYS GRANT TO ADVANCE ORTHO-M DEVELOPMENT FOR MENISCUS REPAIR Canada NewsWire Meniscus indication confirms proprietary technology platform multi-indications potential Grant to accelerate development of sec...
ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS FOURTH QUARTER AND 2022 YEAR-END RESULTS Canada NewsWire Phase I/II clinical trial IND application cleared by FDA for testing ORTHO-R in combination with PRP for rotator cuff tear repair ORTHO-R / PRP combination be...
ORTHO REGENERATIVE TECHNOLOGIES RECEIVES KEY U.S. COMPOSITION AND METHOD PATENT FOR ORTHO-R SOFT TISSUE REPAIR PLATFORM Canada NewsWire New patent issued by U.S. Patent and Trademark Office to protect core IP until 2035 Positions Company as leading player...
ORTHO REGENERATIVE TECHNOLOGIES CLOSES OVERSUBSCRIBED NON-BROKERED PRIVATE PLACEMENT FOR $3.2 MILLION Canada NewsWire Proceeds to be used to accelerate the ORTHO-R Phase I/II US Clinical trial for rotator cuff tear repair Insiders contribute approxima...
News, Short Squeeze, Breakout and More Instantly...
Ortho Regenerative Technologies Inc. Company Name:
ORTH:CC Stock Symbol:
CNQC Market:
Toronto, Ontario--(Newsfile Corp. - Le 7 septembre/September 2022) - Ortho Regenerative Technologies Inc. (ORTH) has announced a name and symbol change to ChitogenX Inc. (CHGX) Shares will begin trading under the new name and symbol and with a new CUSIP number on September 12, 2022. Di...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX Canada NewsWire New Name to better represent Company's proprietary technology platform expanded applications beyond orthopedics MONTREAL , Sept. 7, 2022 /CNW Telbec/ ...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL Canada NewsWire First patient surgery completed; additional surgeries already scheduled 8 clinical centres now fully initi...